Great efforts have been made to develop novel and efficacious therapeutics against pancreatic cancer to improve the treatment outcomes. Tumor-necrosis factor-related apoptosis-inducing ligand (TRAIL) is such a therapeutic cytokine with selective killing effect toward malignant cells. However. some human pancreatic cancers are intrinsically resistant to TRAIL-mediated apoptosis or ther... https://www.lightemupsequences.com/